SAN DIEGO, Calif. — Silicon Biosys­tems Menarini and Macrogen, Inc. announced they will form a partnership to provide clinical assays and innovative procedures for precision medicine in cancer. The goal of the collaboration is to combine Silicon Biosystems’ DEPArray™ digital-sorting technology with Macrogen’s high-throughput Next Generation Sequencing capabilities toward the development of tests certified under […]

SCHLIEREN, Switzerland, – The Volpi Group, a 60-year-old optical electronics firm based in Schlieren, Switzerland, announced that it is collaborating with QIAGEN Instruments AG on the manufacture of the automated fluorescence imaging module used in QIAGEN’s GeneReaderTM next-generation sequencing (NGS) instrument. The benchtop GeneReader combines with other QIAGEN NGS products to provide the first seamless, […]

St. Louis, MO and San Francisco, CA – Cofactor Genomics, a leader in RNA products and applications, announced that they have acquired San Francisco, CA based Narus Biotechnologies, a biomarker development company focused on creating RNA diagnostic tests for neurological diseases that can help inform therapeutic selection for patients with Multiple Sclerosis, Alzheimer’s and Parkinson’s. […]

BC Platforms, a world leader in genomic data management solutions, announced that it has signed a contract with Nexus Personalized Health Technologies to create a joint translational research driven offering connecting genetic and clinical information to enable new innovative patient centric solutions in healthcare. Nexus is a leading provider of services to biomedical researchers in […]

SAN DIEGO, Calif. – Agena Bioscience announced its partnership with DaRui Biotechnology to co-develop a menu of in vitro diagnostic tests for oncology and inherited diseases on its MassARRAY® System for targeted genetic analysis. “The China Market is a significant opportunity for Agena Bioscience, representing twenty percent of our global business. This past year, we […]

MOUNTAIN VIEW, Calif. & BALTIMORE –DNAnexus Inc., the global leader in cloud-based genome informatics and data management, today announced the integration of its cloud-based genomics platform with Sapio Sciences’ Exemplar Next Generation Sequencing (NGS) Laboratory Information Management System (LIMS) solution for clinical and research labs. Organizations and their labs now have a cloud-based, sample-to-answer tracking […]

Venaxis®, Inc. (Nasdaq: APPY), announced that it has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited (Strand LS) and its shareholders. Strand LS is a privately-held, global genomics and bioinformatics company. Strand LS operates clinical reference labs in the US through its wholly owned subsidiary Strand Genomics, Inc., […]

WALTHAM, Mass. (USA) — PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has completed the acquisition of Vanadis Diagnostics, AB. Based in Sweden, Vanadis is developing a novel solution for non-invasive prenatal testing (NIPT) based on digital analysis of cell-free DNA. The […]

MediSapiens Ltd., a Finnish developer and provider of Bio-IT solutions for research and biomedicine, is a partner in an international consortium aiming at developing personalized medicine applications using integrated genome and other health data. The consortium was founded and is headed by the Competence Centre on Health Technologies of Estonia (CCHT) in the framework of […]

Paris, France and Cambridge, UK – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, announced that it has entered into a definitive agreement to acquire the entire share capital of Primer Design Ltd, a profitable and rapidly growing UK molecular diagnostics company. Under the terms of the agreement, Novacyt will acquire […]